Table 6 Histological findings in claws of suckling piglets (SP), weaners (WE) and fatteners (FA)
| Â | SPa | WEb | FAc | SP | Â | WE | Â | FA | Â |
|---|---|---|---|---|---|---|---|---|---|
Macroscopic conspicuous | 17.39% | 44.14% | 95.15% | 0d | 1e | 0d | 1e | 0d | 1e |
n | 115 | 111 | 103 | 95 | 20 | 62 | 49 | 5 | 98 |
Inflammation | 21.74% | 22.52% | 5.83% | 7f (7.4%g) | 18 (90%) | 10 (16.1%) | 15 (30.6%) | 3 (60%) | 3 (3.1%) |
Inflammation: lymphoplasmacellular | 6.09% | 15.32% | 4.85% | 7 (7.4%) | 0 (0%) | 10 (16.1%) | 7 (14.3%) | 3 (60%) | 2 (2%) |
Inflammation: mononuclear | 0% | 0% | 0% | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Inflammation: mixed cellular | 2.61% | 1.8% | 0% | 1 (1.1%) | 2 (10%) | 0 (0%) | 2 (4.1%) | 0 (0%) | 0 (0%) |
Inflammation: purulent | 13.91% | 3.6% | 0% | 1 (1.1%) | 15 (75%) | 0 (0%) | 4 (8.2%) | 0 (0%) | 0 (0%) |
Inflammation: eosinophil | 0% | 0% | 0% | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Inflammation: necrotizing | 0% | 0% | 0% | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Inflammation: necrosuppurative | 0.87% | 0.9% | 0% | 0 (0%) | 1 (5%) | 0 (0%) | 1 (2%) | 0 (0%) | 0 (0%) |
Necrosis | 15.65% | 5.41% | 0.97% | 1 (1.1%) | 17 (85%) | 0 (0%) | 6 (12.2%) | 0 (0%) | 1 (1%) |
Spatial association between inflammation and necrosis | 15.65% | 5.41% | 0.97% | 1 (1.1%) | 17 (85%) | 0 (0%) | 6 (12.2%) | 0 (0%) | 1 (1%) |
Bleeding | 20% | 2.7% | 0% | 13 (13.7%) | 10 (50%) | 3 (4.8%) | 0 (0%) | 0 (0%) | 0 (0%) |
Bleeding hemosiderosis | 0% | 0% | 0% | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Epithelial hyperplasia | 66.09% | 68.47% | 9.71% | 58 (61.1%) | 18 (90%) | 49 (79%) | 27 (55.1%) | 5 (100%) | 5 (5.1%) |
Epithelial hyperplasia: regular | 0.87% | 0% | 0% | 0 (0%) | 1 (5%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Epithelial hyperplasia: irregular | 65.22% | 68.47% | 10.68% | 58 (61.1%) | 17 (85%) | 49 (79%) | 27 (55.1%) | 5 (100%) | 6 (6.1%) |
Epithelial hyperplasia: papillary | 0% | 0% | 0% | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Epithelial hyperplasia: psoriasiform | 0% | 0.9% | 0% | 0 (0%) | 0 (0%) | 0 (0%) | 1 (2%) | 0 (0%) | 0 (0%) |
Epithelial hyperplasia: pseudocarcinomatous | 0% | 0% | 0% | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Epithelial hyperplasia papillary irregular | 0% | 0% | 0% | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Epithelial hyperplasia papillary regular | 0% | 0% | 0% | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Hyperkeratosis | 13.91% | 5.41% | 0.97% | 1 (1.1%) | 15 (75%) | 1 (1.6%) | 5 (10.2%) | 0 (0%) | 1 (1%) |
Hyperkeratosis: orthokeratotic | 0% | 1.8% | 0.97% | 0 (0%) | 0 (0%) | 1 (1.6%) | 1 (2%) | 0 (0%) | 1 (1%) |
Hyperkeratosis: parakeratotic | 13.91% | 3.6% | 0% | 1 (1.1%) | 15 (75%) | 0 (0%) | 4 (8.2%) | 0 (0%) | 0 (0%) |
Claw papilliform structure | 0% | 0% | 0% | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |